Full name
BIOVIRTUS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
55.10.Z - Hotels and similar accommodation
55.20.Z - Holiday and other short-stay accommodation
58.11.Z - Book publishing
70.2 - Management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
75.00.Z - Veterinary activities
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -0 | -0 | -26,3 |
Gross profit (loss) | -0,1 | 0,1 | -0,1 | -175,2 |
EBITDA | -0,1 | -0 | -0 | -26,3 |
Short time liabilities | 0 | 0 | 0 | 0 |
Other operating costs | 0,1 | 0 | 0 | 0 |
Equity capital | -0,1 | 0,1 | 0 | -71,2 |
Operating profit (EBIT) | -0,1 | -0 | -0 | -26,3 |
Assets | 7,4 | 0,1 | 0 | -70,1 |
Net profit (loss) | -0,1 | 0,1 | -0,1 | -176,4 |
Cash | 4,7 | 0,1 | 0 | -70,1 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 7,5 | 0 | 0 | 0 |
Working assets | 4,7 | 0,1 | 0 | -70,1 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 101,6 | -246,7 | -348,3 | |
Equity capital to total assets | -1,2 | 98,5 | 95,1 | -3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 | |
Current financial liquidity indicator | 372.9295959472656 | 20.24412727355957 | -352,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane